| Qatar | | |
Prevalence of obesity among children and adolescents (5?19 years) (%) | 19.5% (2016) [13/190countries] | | | Age-standardized prevalence of obesity among adults (18+ years) (%) | 35.1% (2016) [15/190countries] | | |
|
| Qatar | | |
Prevalence of anaemia in women of reproductive age (15?49 years) (%) | 28.1% (2019) [85/192countries] | | | Age-standardized prevalence of hypertension among adults aged 30-79 years (%) | 40.9% (2019) [66/192countries] | | |
|
| Qatar | | |
Age-standardized prevalence of tobacco use among persons 15 years and olders (%) | 11.8% (2020) [123/164countries] | | |
|
| Qatar | | |
New HIV infections (per 1000 uninfected population) | 0.07 (2020) [87/130countries] | | | Tuberculosis incidence (per 100,000 population) | 42.0 (2021) [105/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.1 (2020) [132/194countries] | | | Reported number of people requiring interventions against NTDs | 23 (2021) [26/83countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 10.7 (2019) [154/183countries] | | |
|
| Qatar | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 107.2 (2020) [160/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 4.7 (2020) [80/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 2.1 (2020) [110/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 42.7 (2020) [103/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 4.1 (2020) [173/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 6.0 (2020) [121/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 3.7 (2020) [127/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 1.3 (2020) [35/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 2.2 (2020) [107/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.1 (2020) [126/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 4.8 (2020) [100/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 2.2 (2020) [84/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 5.0 (2020) [106/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 9.2 (2020) [110/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 0.8 (2020) [178/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.1 (2020) [105/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [117/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 6.4 (2020) [96/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 2.5 (2020) [88/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.0 (2020) [172/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 6.7 (2020) [78/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 3.4 (2020) [105/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 21.1 (2020) [139/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 5.2 (2020) [100/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.6 (2020) [115/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 2.6 (2020) [121/184countries] | | |
|
| Qatar | | |
Suicide, age-standardized (per 100 000 population) | 4.66 (2019) [145/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 5.66 (2019) [156/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 1.69 (2019) [154/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 6.94 (2019) [71/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 8.70 (2019) [79/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.88 (2019) [124/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 7.33 (2019) [100/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 8.25 (2019) [130/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.04 (2019) [90/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 7.48 (2019) [115/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 8.93 (2019) [140/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 2.63 (2019) [132/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 5.30 (2019) [150/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 6.39 (2019) [159/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 0.92 (2019) [171/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 3.03 (2019) [173/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 3.57 (2019) [177/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 0.78 (2019) [178/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 4.65 (2019) [167/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 5.15 (2019) [177/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 3.14 (2019) [138/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 10.27 (2019) [133/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 14.96 (2019) [139/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 6.01 (2019) [113/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 22.26 (2019) [109/183countries] | | |
|
| Qatar | | |
Density of medical doctors (per 10,000 population) | 25.0 (2013?2021) [70/192countries] | | | Density of nursing and midwifery personnel (per 10,000 population) | 72.4 (2013?2021) [42/195countries] | | | Density of dentists (per 10,000 population) | 6.2 (2013?2021) [55/171countries] | | | Density of pharmacists (per 10,000 population) | 8.9 (2013?2021) [32/175countries] | | | Hospital beds (number per 1,000 population) | 1.3 (2017) [85/110countries] | | | Population with household expenditures on health > 10% of total household expenditure or income (%) | 1.3 (2013?2021) [123/132countries] | | |
|
|